Goldman Sachs raised the firm’s price target on Bath & Body Works to $26 from $17 and keeps a Neutral rating on the shares. The company’s new business strategy announced in November 2025 pushes out growth expectations, and management’s strategy change signifies a notable change in the prior business thesis, the analyst tells investors in a research note.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BBWI:
- Bath & Body Works price target lowered to $22 from $23 at JPMorgan
- Bath & Body Works price target raised to $25 from $21 at Barclays
- Bath & Body Works Charts Turnaround Amid 2026 Squeeze
- Wells Fargo recommends buying pullback on Bath & Body Works
- Bath & Body Works price target raised to $30 from $26 at BofA